Early diagnosis of brain metastases through biofluid metabolomics
Over 20% of cancer patients develop brain metastases. Current MRI diagnostic techniques only detect late stage metastases, since they rely on blood-brain-barrier permeability to allow contrast enhancement. Thus, new methods enabling earlier diagnosis are urgently needed. We have previously shown tha...
| Main Authors: | , , , , |
|---|---|
| Format: | Conference item |
| Published: |
Oxford University Press
2017
|